The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $7,466,121 were sold by Dudum Andrew on Feb 18 ’25. At $58.27 per share, Dudum Andrew sold 128,127 shares. The insider’s holdings dropped to 97,687 shares worth approximately $6.49 million following the completion of this transaction.
Also, Dudum Andrew sold 47,534 shares, netting a total of over 2,763,942 in proceeds. Following the sale of shares at $58.15 each, the insider now holds 427,796 shares.
Before that, Boughton Soleil had sold 4,152 shares from its account. In a trade valued at $251,985, the Chief Legal Officer traded Hims & Hers Health Inc shares for $60.69 each. Upon closing the transaction, the insider’s holdings decreased to 4,152 shares, worth approximately $10.45 million.
As published in a research note from Morgan Stanley on February 18, 2025, Hims & Hers Health Inc [HIMS] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $60 from $42. Analysts at Citigroup downgraded the stock from ‘”a Neutral”‘ to ‘”a Sell”‘ outlook in a report released in early January. As of January 07, 2025, BTIG Research has initiated its “Buy” rating for HIMS. Earlier on December 17, 2024, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for HIMS stock.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 43.31%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 174.65%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $24.07 on 01/10/25. A 50-day SMA is recorded $34.51, while a 200-day SMA reached $23.46. Nevertheless, trading volume fell to 30.67 million shares from 59.52 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 61.55, which, if violated, would cause prices to drop to 56.68. In the upper region, resistance lies at 69.33. The next price resistance is at 72.24. RSI (Relative Strength Index) is 81.50 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 15.17, which suggests the price will increase in the coming days. Percent R is at 16.72%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
